Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Italiano

Showing results (1-10 of 418) with videos related to

Pageof 42
Sort By:
Pharmacology & Therapeutics|May 16, 2016
Role of the EZH2 histone methyltransferase as a therapeutic target in cancerAntoine Italiano
Current Opinion in Oncology|June 22, 2022
Next questions for the medical treatment of gastrointestinal stromal tumorAntoine Italiano
Current Treatment Options in Oncology|December 8, 2018
Is There Value in Molecular Profiling of Soft-Tissue Sarcoma?Antoine Italiano
Cancer Discovery|May 18, 2021
ATR Inhibition as an Attractive Therapeutic Resource against CancerAntoine Italiano
Oncology|May 6, 2006
Targeting the epidermal growth factor receptor in colorectal cancer: advances and controversiesAntoine Italiano
Expert Opinion on Pharmacotherapy|December 14, 2020
New insights into the clinical management of advanced gastrointestinal stromal tumorsAntoine Italiano
Journal of Hematology & Oncology|April 9, 2020
Targeting epigenetics in sarcomas through EZH2 inhibitionAntoine Italiano
Cancer Discovery|August 4, 2023
Targeting MDM2 in Soft-Tissue Sarcomas (and Other Solid Tumors): The Revival?Antoine Italiano
Expert Opinion on Pharmacotherapy|May 5, 2017
Clinical efficacy of eribulin mesylate for the treatment of metastatic soft tissue sarcomaSheik Emambux, Antoine Italiano
Expert Opinion on Biological Therapy|July 11, 2017
Olaratumab for soft tissue sarcomaDiego Teyssonneau, Antoine Italiano
Pageof 42

Showing results (1-10 of 418) with videos related to

Sort By:
Pageof 42
Pharmacology & Therapeutics|May 16, 2016
Role of the EZH2 histone methyltransferase as a therapeutic target in cancerAntoine Italiano
Current Opinion in Oncology|June 22, 2022
Next questions for the medical treatment of gastrointestinal stromal tumorAntoine Italiano
Current Treatment Options in Oncology|December 8, 2018
Is There Value in Molecular Profiling of Soft-Tissue Sarcoma?Antoine Italiano
Cancer Discovery|May 18, 2021
ATR Inhibition as an Attractive Therapeutic Resource against CancerAntoine Italiano
Oncology|May 6, 2006
Targeting the epidermal growth factor receptor in colorectal cancer: advances and controversiesAntoine Italiano
Expert Opinion on Pharmacotherapy|December 14, 2020
New insights into the clinical management of advanced gastrointestinal stromal tumorsAntoine Italiano
Journal of Hematology & Oncology|April 9, 2020
Targeting epigenetics in sarcomas through EZH2 inhibitionAntoine Italiano
Cancer Discovery|August 4, 2023
Targeting MDM2 in Soft-Tissue Sarcomas (and Other Solid Tumors): The Revival?Antoine Italiano
Expert Opinion on Pharmacotherapy|May 5, 2017
Clinical efficacy of eribulin mesylate for the treatment of metastatic soft tissue sarcomaSheik Emambux, Antoine Italiano
Expert Opinion on Biological Therapy|July 11, 2017
Olaratumab for soft tissue sarcomaDiego Teyssonneau, Antoine Italiano
Pageof 42